HP Inc. Looks Outside Tech, Tapping Pharma Heavyweight as New CEO — Barrons.com

What happened

HP named former GSK chief Emma Walmsley as its new CEO, succeeding interim CEO Bruce Broussard on Jan. 4. Broussard will become chairman, replacing Chip Bergh. Walmsley led GSK from early 2017 through the end of 2025 and has served on Microsoft’s board for seven years.

Confirmed

Global impact / market context

Walmsley brings leadership experience from pharmaceuticals and consumer goods rather than running a technology company, while her Microsoft board service gives her some technology-sector exposure. Her decisions could shape HP’s response to AI-related changes and pressure on computer sales from rising memory-chip costs.

Analyst inference

The appointment arrives as higher memory-chip costs are pressuring sales of personal computers and laptops, while HP expects industrywide volumes to fall by a mid-single-digit percentage in 2027. Together, weaker sales and more expensive components could constrain revenue and profit per sale.

Analyst inference

What to watch

1. Watch for HP’s Jan. 4 leadership handover: Walmsley is due to become CEO and Broussard chairman, creating a clear point for assessing management continuity. Confirmed
2. Look for HP’s future comments on AI moving to the edge, meaning AI processing closer to devices, and whether it plans changes to products or spending. Analyst inference
3. Track updates on memory-chip costs and computer volumes; if costs stay high while sales fall, HP could face pressure on revenue and profit per sale. Analyst inference

Evidence

• Original source link unavailable